Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07006142 · ClinicalTrials.gov registry record · NA
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists
A NA study of Upper Endoscopy and GLP1-R-related Disease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT07006142: Recruiting NA study of Upper Endoscopy and GLP1-R-related Disease, sponsored by Mayo Clinic.
NCT07006142 is a NA study of Upper Endoscopy and GLP1-R-related Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07006142, a NA study of Upper Endoscopy and GLP1-R-related Disease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
Conditions Studied
Interventions
- OTHER Modified Fasting Guidelines
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07006142
The ClinicalTrials.gov registry entry for NCT07006142 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Upper Endoscopy appearing as the primary indexed condition, and to 1 intervention - of which Modified Fasting Guidelines is the first listed.
NCT07006142 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07006142 about?
NCT07006142 is a clinical study titled "Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists". The aim of this study is to determine whether a modified fasting protocol can reduce the potential risk of aspiration for patients currently prescribed GLP1-RAs.
What is the current status of trial NCT07006142?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-08-01. Estimated completion is 2026-04-30.
What conditions does trial NCT07006142 study?
This clinical trial studies the following conditions: Upper Endoscopy, GLP1-R-related Disease.
What interventions are being tested in trial NCT07006142?
The interventions under investigation include: Modified Fasting Guidelines (OTHER).
Who is sponsoring clinical trial NCT07006142?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07006142 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.